Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
Clinical trial NCT06114407 · UNKNOWN
Trial details
- NCT number
- NCT06114407
- Sponsor
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-30
- Primary completion
- 2024-06-30
- Enrollment
- 184
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.